Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract PR01: Regulation of exhausted CD8⁺ T cell differentiation by IKZF transcription factors

Sinead M Reading, Isabelle Munoz, Maria Nogueira de Menezes, Nicole Y.L Saw, Krutika Ambani, Antonio Ahn, Simone Nussing, Sara Roth, Shienny Sampurno, Kelly M Ramsbottom, Joseph A Trapani, Kim L Good-Jacobson, Ricky W Johnstone, Shom Goel, Paul A Beavis, Ian A Parish

Cancer Immunol Res (2023) 11 (12_Supplement): PR01.

https://doi.org/10.1158/2326-6074.TUMIMM23-PR01

Published: 01 December 2023

View article titled, Abstract PR01: Regulation of exhausted CD8+ T cell differentiation by IKZF transcription factors

Journal Articles

TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity

Fernando Souza-Fonseca-Guimaraes, Gustavo R. Rossi, Laura F. Dagley, Momeneh Foroutan, Timothy R. McCulloch, Jumana Yousef, Hae-Young Park, Jennifer H. Gunter, Paul A. Beavis, Cheng-Yu Lin, Soroor Hediyeh-Zadeh, Tania Camilleri, Melissa J. Davis, Nicholas D. Huntington

Cancer Immunol Res (2022) 10 (9): 1047–1054.

https://doi.org/10.1158/2326-6066.CIR-21-1052

Published: 01 September 2022

View article titled, TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity

Includes: Supplementary data

Journal Articles

Antagonism of IAPs Enhances CAR T-cell Efficacy

Jessica Michie, Paul A. Beavis, Andrew J. Freeman, Stephin J. Vervoort, Kelly M. Ramsbottom, Vignesh Narasimhan, Emily J. Lelliott, Najoua Lalaoui, Robert G. Ramsay, Ricky W. Johnstone, John Silke, Phillip K. Darcy, Ilia Voskoboinik, Conor J. Kearney, Jane Oliaro

Cancer Immunol Res (2019) 7 (2): 183–192.

https://doi.org/10.1158/2326-6066.CIR-18-0428

Published: 01 February 2019

View article titled, Antagonism of IAPs Enhances CAR T-cell Efficacy

Includes: Multimedia, Supplementary data

Journal Articles

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4⁺Foxp3⁻ Cell–Mediated Modulation of CD103⁺ Dendritic Cells

Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida, Alexander J. Davenport, Emma V. Petley, Imran G. House, Junyun Lai, Kevin Sek, Nicole Milenkovski, Liza B. John, Sherly Mardiana, Clare Y. Slaney, Joseph A. Trapani, Sherene Loi, Michael H. Kershaw, Nicole M. Haynes, Phillip K. Darcy

Cancer Immunol Res (2018) 6 (9): 1069–1081.

https://doi.org/10.1158/2326-6066.CIR-18-0291

Published: 04 September 2018

View article titled, Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells

Includes: Supplementary data

Journal Articles

Abstract A105: Cross-talk between tumors can affect responses to therapy

Christel Devaud, Jennifer A. Westwood, Liza John, Carmen S.M. Yong, Paul A. Beavis, Linda A. Snyder, Reto A. Schwendener, Darcy K. Phillip, Michael H. Kershaw

Cancer Immunol Res (2016) 4 (1_Supplement): A105.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A105

Published: 03 January 2016

View article titled, Abstract A105: Cross-talk between tumors can affect responses to therapy

Journal Articles

Abstract A104: Eradication of large solid tumors in immunocompetent mice using dual specific CAR T cells and vaccination

Clare Y. Slaney, Jennifer A. Westwood, Paul A. Beavis, Phillip K. Darcy, Michael H. Kershaw

Cancer Immunol Res (2016) 4 (1_Supplement): A104.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A104

Published: 03 January 2016

View article titled, Abstract A104: Eradication of large solid tumors in immunocompetent mice using dual specific CAR T cells and vaccination

Journal Articles

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Paul A. Beavis, Nicole Milenkovski, Melissa A. Henderson, Liza B. John, Bertrand Allard, Sherene Loi, Michael H. Kershaw, John Stagg, Phillip K. Darcy

Cancer Immunol Res (2015) 3 (5): 506–517.

https://doi.org/10.1158/2326-6066.CIR-14-0211

Published: 03 May 2015

View article titled, Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Includes: Supplementary data

NARROW

Abstract PR01: Regulation of exhausted CD8⁺ T cell differentiation by IKZF transcription factors

TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity

Antagonism of IAPs Enhances CAR T-cell Efficacy

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4⁺Foxp3⁻ Cell–Mediated Modulation of CD103⁺ Dendritic Cells

Abstract A105: Cross-talk between tumors can affect responses to therapy

Abstract A104: Eradication of large solid tumors in immunocompetent mice using dual specific CAR T cells and vaccination

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Email alerts

AACR Journals

Abstract PR01: Regulation of exhausted CD8+ T cell differentiation by IKZF transcription factors

TGFβ and CIS Inhibition Overcomes NK-cell Suppression to Restore Antitumor Immunity

Antagonism of IAPs Enhances CAR T-cell Efficacy

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3− Cell–Mediated Modulation of CD103+ Dendritic Cells

Abstract A105: Cross-talk between tumors can affect responses to therapy

Abstract A104: Eradication of large solid tumors in immunocompetent mice using dual specific CAR T cells and vaccination

Adenosine Receptor 2A Blockade Increases the Efficacy of Anti–PD-1 through Enhanced Antitumor T-cell Responses

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Abstract PR01: Regulation of exhausted CD8⁺ T cell differentiation by IKZF transcription factors

Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4⁺Foxp3⁻ Cell–Mediated Modulation of CD103⁺ Dendritic Cells